Strategic HEOR Partner FIECON sits within Acumetis as the Health Economics & Outcomes Research practice, offering robust value evidence and access strategies across asset lifecycles, which presents opportunities to upsell HEOR-led outcomes research, value dossiers, and payer-facing materials to life sciences teams seeking faster patient access.

Global Access Focus The firm emphasizes accelerating patient access worldwide and integrating commercial support across the asset lifecycle, indicating potential to cross-sell to clients pursuing global reimbursement strategies, market access planning, and launch readiness services.

Innovation & Efficiency Proprietary modelling platforms and innovative thinking are core to FIECON, suggesting sales angles around scalable, rigorous evidence generation and faster decision-ready insights that reduce time-to-treatment and improve launch efficiency.

Sustainable Value Narrative A mission-driven approach with charitable giving and responsible business practices can resonate with customers prioritizing ESG-aligned partners, creating opportunities to differentiate in proposals and expand into sustainability-focused value demonstrations.

Brand & Expansion Potential Recent branding partnerships and alignment with BrandingBusiness signal growth and broader market visibility, creating openings to position FIECON as a trusted HEOR partner for branding, market access, and commercial strategy engagements within life sciences.